These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 35179274)

  • 21. A case of atopic dermatitis-associated dupilumab-resistant alopecia totalis successfully treated with baricitinib.
    Seo T; Izumi K; Kawamura T; Tsujiwaki M; Ujiie H
    Dermatol Ther; 2022 Dec; 35(12):e15953. PubMed ID: 36269309
    [No Abstract]   [Full Text] [Related]  

  • 22. Effect of Ivabradine in dilated cardiomyopathy from Duchenne muscular dystrophy: A chance for slowing progression of heart failure?
    De Benedittis G; Della Rosa G; D'Ettorre E; Piscitelli P; Distante A; de Gregorio C
    Int J Cardiol; 2016 Nov; 223():286-288. PubMed ID: 27541675
    [No Abstract]   [Full Text] [Related]  

  • 23. Be careful about abdominal discomfort in adult patients with muscular dystrophy.
    Fayssoil A; Ritzenthaler T; Luis D; Hullin T; Clair B; Annane D; Orlikowski D
    Rev Neurol (Paris); 2014; 170(8-9):548-50. PubMed ID: 25189677
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Severe atopic dermatitis: Dupilumab is not just safer, but more efficient.
    Giavina-Bianchi M; Rizzo LV; Giavina-Bianchi P
    Allergol Immunopathol (Madr); 2020; 48(6):792-797. PubMed ID: 32249095
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Levosimendan as Rescue Therapy for Acute Heart Failure in a Patient with Duchenne Muscular Dystrophy.
    Sumanaru D; Josseran L; Essid A; Mbieleu B; Haegy I; Bergounioux J
    Pediatr Cardiol; 2019 Mar; 40(3):668-670. PubMed ID: 30796500
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Severe atopic dermatitis in a patient with Loeys-Dietz syndrome treated with dupilumab.
    Gkalpakiotis S; Maresova T
    J Eur Acad Dermatol Venereol; 2023 Jan; 37(1):e70-e72. PubMed ID: 35964299
    [No Abstract]   [Full Text] [Related]  

  • 27. EASI p-EASI: Predicting disease severity in atopic dermatitis patients treated with dupilumab using a combination of serum biomarkers.
    Bakker DS; Ariens LFM; Giovannone B; Hijnen D; Delemarre EM; Knol E; Nierkens S; de Bruin-Weller MS; Thijs JL; Drylewicz J
    Allergy; 2020 Dec; 75(12):3287-3289. PubMed ID: 33305359
    [No Abstract]   [Full Text] [Related]  

  • 28. Simultaneous effectiveness of dupilumab in atopic dermatitis and alopecia areata in two patients.
    Ludriksone L; Elsner P; Schliemann S
    J Dtsch Dermatol Ges; 2019 Dec; 17(12):1278-1280. PubMed ID: 31829527
    [No Abstract]   [Full Text] [Related]  

  • 29. Dupilumab for the treatment of atopic dermatitis in transplant patients: Two case reports and literature review.
    Napolitano M; Nocerino M; Picone V; Martora F; Fabbrocini G; Dastoli S; Patruno C
    Dermatol Ther; 2022 Apr; 35(4):e15324. PubMed ID: 35048522
    [No Abstract]   [Full Text] [Related]  

  • 30. Improved sleep in adults with atopic dermatitis using the treatment dupilumab.
    Br J Dermatol; 2023 Nov; 189(6):e106. PubMed ID: 37972138
    [No Abstract]   [Full Text] [Related]  

  • 31. A case of lichen amyloidosis associated with atopic dermatitis successfully treated with dupilumab: A case report and literature review.
    Aoki K; Ohyama M; Mizukawa Y
    Dermatol Ther; 2021 Jul; 34(4):e15005. PubMed ID: 34037298
    [No Abstract]   [Full Text] [Related]  

  • 32. Severe atopic dermatitis in a 21-month-old boy successfully treated with dupilumab.
    Mazzoni D; Lobo Y; Levitt D; Wheller L
    Pediatr Dermatol; 2022 Jul; 39(4):606-608. PubMed ID: 35575257
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Safe and effective treatment of atopic dermatitis using dupilumab over 23 months in a patient with HIV.
    Lor M; Villa N; Holland V
    Dermatol Ther; 2020 Nov; 33(6):e14271. PubMed ID: 32882092
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Safety of dupilumab in a 5-month-old infant with severe atopic dermatitis.
    Havele SA; Khurana MC; McMahon P; Murthy AS; Perman MJ; Treat JR
    Pediatr Dermatol; 2022 Mar; 39(2):291-294. PubMed ID: 35434859
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Ocular symptoms associated with dupilumab in atopic dermatitis].
    Voorberg AN; Oosterhaven JAF; Wijdh RHJ; de Bruin-Weller MS; Schuttelaar MLA
    Ned Tijdschr Geneeskd; 2019 Mar; 163():. PubMed ID: 30945835
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serum IL-22 binding protein as a marker for atopic dermatitis activity and response to dupilumab treatment.
    Varandas C; Pereira-Santos MC; Neto M; Sousa AE; Lopes A; Silva SL
    Clin Exp Allergy; 2022 Jun; 52(6):820-823. PubMed ID: 35416344
    [No Abstract]   [Full Text] [Related]  

  • 37. Acute onset of psoriasis in a patient with atopic dermatitis treated with dupilumab.
    Ferrucci S; Tavecchio S; Berti E; Angileri L
    Clin Exp Dermatol; 2020 Jul; 45(5):625-626. PubMed ID: 32112580
    [No Abstract]   [Full Text] [Related]  

  • 38. Concurrent use of omalizumab and dupilumab in a 47-year-old woman with chronic spontaneous urticaria and atopic dermatitis.
    Holm JG; Sørensen JA; Thomsen SF
    Int J Dermatol; 2022 May; 61(5):e173-e174. PubMed ID: 34813086
    [No Abstract]   [Full Text] [Related]  

  • 39. A Case of Refractory Heart Failure in Becker Muscular Dystrophy Improved With Corticosteroid Therapy.
    Nakamura M; Sunagawa O; Hokama R; Tsuchiya H; Miyara T; Taba Y; Touma T
    Int Heart J; 2016 Sep; 57(5):640-4. PubMed ID: 27535714
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy and safety of dupilumab monotherapy in adults with moderate-to-severe atopic dermatitis: a pooled analysis of two phase 3 randomized trials (LIBERTY AD SOLO 1 and LIBERTY AD SOLO 2).
    Thaçi D; L Simpson E; Deleuran M; Kataoka Y; Chen Z; Gadkari A; Eckert L; Akinlade B; Graham NMH; Pirozzi G; Ardeleanu M
    J Dermatol Sci; 2019 May; 94(2):266-275. PubMed ID: 31109652
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.